Profile
Mary Carmen Diez has worked as a VP-Medical Affairs & New Product Commercialization at TiGenix NV since 2014.
Mary Carmen Diez active positions
| Companies | Position | Start |
|---|---|---|
| TIGENIX NV | Corporate Officer/Principal | 2014-09-17 |
Experiences
Positions held
Connections
17
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
- Stock Market
- Insiders
- Mary Carmen Diez
